Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Histone lysine demethylase 4 (KDM4), also known as the JMJD2 family, is a subfamily of histone demethylases that catalyze the removal of methyl groups from specific lysine residues on histones H3K9 and H3K36. This process is a key epigenetic mechanism regulating chromatin structure and gene expression. Overexpression or amplification of KDM4 is implicated in various cancers, making it a potential therapeutic target.
Oxidative demethylation using Fe(II) and alpha-ketoglutarate as cofactors
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Histone Lysine Demethylase 4 (KDM4).